Insider Cluster (2 insiders) ·Filed Mar 30, 2026

INSM

INSMED Inc
BEARISH
Impact 5/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $4.1M total
Actionable Insight ▼ Bearish

Monitor for potential follow-on selling or lack of insider buying ahead of next earnings. While the dollar amount is not highly material, coordinated C-suite selling may signal limited near-term upside in the stock at current levels.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
INSM ▼ -31.86% at T+60d
SHORT call ✓ call won +31.86% · α vs SPY +48.35% · entry $153.32 → $104.47
Entry anchored
Mar 27, 03:59 PM ET
via exchange tick
T+1d
+6.65%
call -6.65% · α -3.76%
$163.52
settled 6mo ago
T+5d
+6.33%
call -6.33% · α -2.03%
$163.03
settled 6mo ago
T+20d
-11.99%
call +11.99% · α +24.58%
$134.94
settled 5mo ago
T+60d
-31.86%
call +31.86% · α +48.35%
$104.47
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Insmed sold shares in the past week, generating $4.06 million in total proceeds. The sales were open-market transactions following derivative exercises, with no open-market buying observed. This insider selling represents a modest but notable outflow relative to the company's $35B market cap.

Key Financial Metrics

Direction
selling
Total Value
$4.1M
Insiders
2

Key Facts

  • Chief Operating Officer Roger Adsett sold 6,715 shares for $1.10M on April 1, 2026.
  • Chief Legal Officer Michael Smith sold 19,638 shares for $2.96M on March 30, 2026.
  • Both executives also exercised stock options, including non-cash transactions totaling $1.38M in value.
  • Total open-market selling in the cluster: $4.06M over 7 days.
  • Selling represents approximately 0.012% of Insmed's $35B market cap.

Financial Impact

$4.06 million in open-market insider selling over 7 days

insider ownershipmarket sentiment

Risk Factors

  • Perception of insider pessimism despite routine nature of post-exercise selling
  • Potential for negative market reaction if investors interpret sales as lack of confidence

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1775246891949
18 reports for INSM
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +31.86%Mar 30, 2026
Filters
Rows
Reports for INSM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$130.66 $119.92▼ −8.22%▼ −6.70%$109.99 (−15.82%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$126.33 $129.41▲ +2.44%▲ +4.19%$109.99 (−12.93%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$132.55 $126.68▼ −4.43%▼ −5.03%$109.99 (−17.02%)
Jul 24, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$106.92 $125.77▲ +17.63%▲ +14.00%$109.99 (+2.87%)
Jul 21, 2026
10w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$108.62 $128.46▲ +18.27%▲ +15.70%$109.99 (+1.26%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$107.46 $126.33▲ +17.56%▲ +13.94%$109.99 (+2.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$104.74 $106.92▲ +2.08%▲ +2.36%$109.99 (+5.01%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
May 15, 2026
19w ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $95.52▼ −10.85%▼ −12.44%$109.99 (+2.65%)
Showing 10 of 18

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 3, 2026